Follow
Ángela Rojas
Ángela Rojas
Intituto de Biomedicina de Sevilla
Verified email at us.es
Title
Cited by
Cited by
Year
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
CH Liu, J Ampuero, A Gil-Gómez, R Montero-Vallejo, Á Rojas, ...
Journal of hepatology 69 (6), 1335-1348, 2018
1452018
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
K Thabet, A Asimakopoulos, M Shojaei, M Romero-Gomez, A Mangia, ...
Nature communications 7 (1), 12757, 2016
1192016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
M Eslam, A Mangia, T Berg, HLY Chan, WL Irving, GJ Dore, ML Abate, ...
Hepatology 64 (1), 34-46, 2016
1122016
Effect of quercetin on hepatitis C virus life cycle: from viral to host targets
Á Rojas, JA Del Campo, S Clement, M Lemasson, M García-Valdecasas, ...
Scientific Reports 6 (1), 31777, 2016
1082016
Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry
I Medina-Caliz, M Garcia-Cortes, A Gonzalez-Jimenez, MR Cabello, ...
Clinical Gastroenterology and Hepatology 16 (9), 1495-1502, 2018
1072018
IFN-λ3, not IFN-λ4, likely mediates IFNL3IFNL4 haplotype–dependent hepatic inflammation and fibrosis
M Eslam, D McLeod, KS Kelaeng, A Mangia, T Berg, K Thabet, WL Irving, ...
Nature Genetics 49 (5), 795-800, 2017
992017
Metformin inhibits glutaminase activity and protects against hepatic encephalopathy
J Ampuero, I Ranchal, D Nunez, MM Díaz-Herrero, M Maraver, JA Campo, ...
PLoS One 7 (11), e49279, 2012
822012
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection
I Carmona, P Cordero, J Ampuero, A Rojas, M Romero-Gomez
Clinical microbiology and infection 22 (10), 839-845, 2016
562016
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy
JA Del Campo, M García-Valdecasas, A Gil-Gómez, Á Rojas, P Gallego, ...
PloS one 13 (1), e0191805, 2018
432018
Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro
Á Rojas, JA Del Campo, M Maraver, R Aparcero, M García‐Valdecasas, ...
Journal of viral hepatitis 21 (1), 19-24, 2014
312014
Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study
R Muñoz-Hernández, J Ampuero, R Millán, A Gil-Gómez, Á Rojas, ...
Clinical and translational gastroenterology 11 (8), e00203, 2020
282020
Activation of the oncogenic miR‐21‐5p promotes HCV replication and steatosis induced by the viral core 3a protein
S Clément, C Sobolewski, D Gomes, A Rojas, N Goossens, ...
Liver International 39 (7), 1226-1236, 2019
262019
Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism
JA Del Campo, J Ampuero, L Rojas, M Conde, A Rojas, M Maraver, ...
Alimentary pharmacology & therapeutics 37 (1), 74-80, 2013
262013
The hepatitis C virus modulates insulin signaling pathway in vitro promoting insulin resistance
JA del Campo, M García-Valdecasas, L Rojas, Á Rojas, ...
PLoS One 7 (10), e47904, 2012
252012
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
R Gallego-Durán, J Ampuero, H Pastor-Ramírez, L Álvarez-Amor, ...
Scientific Reports 12 (1), 3418, 2022
192022
Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma
Á Rojas, A Gil‐Gómez, P de la Cruz‐Ojeda, R Muñoz‐Hernández, ...
Liver International 42 (6), 1410-1422, 2022
172022
International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis
Á Díaz‐González, M Sanduzzi‐Zamparelli, LG da Fonseca, ...
Liver International 40 (6), 1467-1476, 2020
172020
Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication
P Gallego, Á Rojas, G Falcón, P Carbonero, MR García-Lozano, A Gil, ...
Food & Function 10 (6), 3758-3767, 2019
172019
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
J Ampuero, C Jimeno, R Quiles, JM Rosales, S Llerena, N Palomo, ...
Journal of hepatology 68 (5), 940-948, 2018
172018
Entry of hepatitis C virus into the cell: a therapeutic target
JA Del Campo, Á Rojas, M Romero-Gómez
World Journal of Gastroenterology: WJG 18 (33), 4481, 2012
162012
The system can't perform the operation now. Try again later.
Articles 1–20